Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients
2021 · Nature Communications · 265 citations
https://doi.org/10.1038/s41467-020-20162-8
L
Lianpeng Chang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
106
Papers
2.5K
Citations
23
h-index
35
i10-index
Lianpeng Chang is an academic researcher. The author has contributed to research in topics: Cancer Genomics and Diagnostics & Lung Cancer Treatments and Mutations & Colorectal Cancer Treatments and Studies. The author has an h-index of 23, co-authored 91 publications.
ORCID: 0000-0002-7649-2748Papers by this author
worksCirculating tumor DNA analyses predict progressive disease and indicate trastuzumab-resistant mechanism in advanced gastric cancer
2019 · EBioMedicine · 107 citations
https://doi.org/10.1016/j.ebiom.2019.04.003
Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer
2019 · International Journal of Cancer · 88 citations
https://doi.org/10.1002/ijc.32536
Comprehensive Molecular Characterization of Young Chinese Patients with Lung Adenocarcinoma Identified a Distinctive Genetic Profile
2018 · The Oncologist · 78 citations
https://doi.org/10.1634/theoncologist.2017-0629
Identifying Circulating Tumor DNA Mutation Profiles in Metastatic Breast Cancer Patients with Multiline Resistance
2018 · EBioMedicine · 76 citations
https://doi.org/10.1016/j.ebiom.2018.05.015
Molecular landscape and efficacy of HER2-targeted therapy in patients with HER2-mutated metastatic breast cancer
2020 · npj Breast Cancer · 71 citations
https://doi.org/10.1038/s41523-020-00201-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat